Clinical Course and Prognostic Factors of Progressive Multifocal Leukoencephalopathy in Patients Treated with Highly Active Antiretroviral Therapy
Open Access
- 15 April 2003
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 36 (8), 1047-1052
- https://doi.org/10.1086/374048
Abstract
We analyzed survival rates, neurologic function, and prognostic factors for 118 consecutive patients with acquired immunodeficiency syndrome-associatThis publication has 26 references indexed in Scilit:
- Epidemiology of Human Immunodeficiency Virus–Associated Opportunistic Infections in the United States in the Era of Highly Active Antiretroviral TherapyClinical Infectious Diseases, 2000
- Intravenous Cidofovir for Compassionate Use in AIDS Patients with Cytomegalovirus RetinitisClinical Infectious Diseases, 2000
- Highly Active Antiretroviral Therapy and Progressive Multifocal Leukoencephalopathy: Effects on Cerebrospinal Fluid Markers of JC Virus Replication and Immune ResponseClinical Infectious Diseases, 2000
- Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitorsAIDS, 1999
- Notes Progressive Multifocal Leukoencephalopathy in Patients with AIDS Receiving Highly Active Antiretroviral TherapyClinical Infectious Diseases, 1999
- Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapyJournal of NeuroVirology, 1999
- Progressive Multifocal LeukoencephalopathySeminars in Neurology, 1999
- Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapyAIDS, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Remission of progressive multifocal leucoencephalopathy after antiretroviral therapyThe Lancet, 1997